Transient alleviation of tumor hypoxia during first days of antiangiogenic therapy as a result of therapy-induced alterations in nutrient supply and tumor metabolism – Analysis by mathematical modeling
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 451, 86-100
Abstract
No abstract availableKeywords
Funding Information
- Russian Science Foundation (14-31-00024)
This publication has 76 references indexed in Scilit:
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabAngiogenesis, 2012
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood PerfusionCancer Research, 2012
- Quantifying the Role of Angiogenesis in Malignant Progression of Gliomas: In Silico Modeling Integrates Imaging and HistologyCancer Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Combination of antiangiogenesis with chemotherapy for more effective cancer treatmentMolecular Cancer Therapeutics, 2008
- Role of autophagy in cancerNature Reviews Cancer, 2007
- Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalizationMicrovascular Research, 2007
- The biology of VEGF and its receptorsNature Medicine, 2003
- The Hallmarks of CancerCell, 2000